Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Hemoglobin E - beta-thalassemia (HbE - BT) is a form of beta-thalassemia that results in a mild to severe clinical presentation ranging from a condition indistinguishable from beta-thalassemia major to a mild form of beta-thalassemia intermedia.
Biomarker and diagnostic research for hemoglobin E-beta-thalassemia syndrome has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for hemoglobin E-beta-thalassemia syndrome.
21 publications have been identified in PubMed for hemoglobin E-beta-thalassemia syndrome. Research spans Epidemiology / Natural History (33%), Basic Science / Preclinical (24%), and Case Report / Case Series (19%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 7 | 33% |
Data assembled from 3 of 12 sources · Last updated Oct 4, 2026, 3:02 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research
5 |
24% |
Patient case studies | 4 | 19% |
Research summaries | 3 | 14% |
Testing and diagnosis research | 1 | 5% |
Clinical study results | 1 | 5% |
Kanyasone V (2026). [PMID: 42091971](https://pubmed.ncbi.nlm.nih.gov/42091971/). *Sci Rep*. [Basic Science / Preclinical]
Cheng AN (2026). [PMID: 42124440](https://pubmed.ncbi.nlm.nih.gov/42124440/). *Hemoglobin*. [Case Report / Case Series]
Dolai TK (2026). [PMID: 41728182](https://pubmed.ncbi.nlm.nih.gov/41728182/). *Indian J Hematol Blood Transfus*. [Review / Meta-Analysis]
Singha A (2025). [PMID: 40049330](https://pubmed.ncbi.nlm.nih.gov/40049330/). *Endocr Pract*. [Epidemiology / Natural History]
Lertsakulbunlue S (2025). [PMID: 40129579](https://pubmed.ncbi.nlm.nih.gov/40129579/). *Anemia*. [Epidemiology / Natural History]
Tatu T (2025). [PMID: 41287207](https://pubmed.ncbi.nlm.nih.gov/41287207/). *Hemoglobin*. [Diagnostic / Biomarker]
Suksusut A (2025). [PMID: 39878036](https://pubmed.ncbi.nlm.nih.gov/39878036/). *Hematology*. [Basic Science / Preclinical]
Schnedl WJ (2025). [PMID: 40016398](https://pubmed.ncbi.nlm.nih.gov/40016398/). *Ann Hematol*. [Case Report / Case Series]
Hossain MS (2025). [PMID: 40640823](https://pubmed.ncbi.nlm.nih.gov/40640823/). *Orphanet J Rare Dis*. [Review / Meta-Analysis]
Aziz NA (2025). [PMID: 41029085](https://pubmed.ncbi.nlm.nih.gov/41029085/). *Medicine (Baltimore)*. [Case Report / Case Series]